Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Garrido

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Current Oncology Reports|April 12, 2022
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of CancerVaia Florou, Ignacio Garrido-Laguna
Nature Reviews. Clinical Oncology|April 1, 2015
Pancreatic cancer: from state-of-the-art treatments to promising novel therapiesIgnacio Garrido-Laguna, Manuel Hidalgo
Future Oncology (London, England)|March 16, 2018
Upper gastrointestinal malignancies in 2017: current perspectives and future approachesBenjamin L Solomon, Ignacio Garrido-Laguna
Cancer Immunology, Immunotherapy : CII|September 21, 2018
TIGIT: a novel immunotherapy target moving from bench to bedsideBenjamin L Solomon, Ignacio Garrido-Laguna
Oncoimmunology|August 31, 2012
Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancerLudovic Martinet, Ignacio Garrido, Jean-Philippe Girard
Nature Reviews. Clinical Oncology|August 3, 2011
The inverted pyramid of biomarker-driven trialsIgnacio Garrido-Laguna, Manuel Hidalgo, Razelle Kurzrock
Oncotargets and Therapy|January 16, 2016
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancerShiven B Patel, David Gill, Ignacio Garrido-Laguna
Nature Reviews. Clinical Oncology|November 10, 2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancerChristopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna
Therapeutic Advances in Medical Oncology|September 23, 2021
Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinomaSiddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna
Surgical Oncology Clinics of North America|September 13, 2021
Therapeutic Targeting of Autophagy in Pancreatic CancerMona Foth, Ignacio Garrido-Laguna, Conan G Kinsey
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Current Oncology Reports|April 12, 2022
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of CancerVaia Florou, Ignacio Garrido-Laguna
Nature Reviews. Clinical Oncology|April 1, 2015
Pancreatic cancer: from state-of-the-art treatments to promising novel therapiesIgnacio Garrido-Laguna, Manuel Hidalgo
Future Oncology (London, England)|March 16, 2018
Upper gastrointestinal malignancies in 2017: current perspectives and future approachesBenjamin L Solomon, Ignacio Garrido-Laguna
Cancer Immunology, Immunotherapy : CII|September 21, 2018
TIGIT: a novel immunotherapy target moving from bench to bedsideBenjamin L Solomon, Ignacio Garrido-Laguna
Oncoimmunology|August 31, 2012
Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancerLudovic Martinet, Ignacio Garrido, Jean-Philippe Girard
Nature Reviews. Clinical Oncology|August 3, 2011
The inverted pyramid of biomarker-driven trialsIgnacio Garrido-Laguna, Manuel Hidalgo, Razelle Kurzrock
Oncotargets and Therapy|January 16, 2016
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancerShiven B Patel, David Gill, Ignacio Garrido-Laguna
Nature Reviews. Clinical Oncology|November 10, 2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancerChristopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna
Therapeutic Advances in Medical Oncology|September 23, 2021
Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinomaSiddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna
Surgical Oncology Clinics of North America|September 13, 2021
Therapeutic Targeting of Autophagy in Pancreatic CancerMona Foth, Ignacio Garrido-Laguna, Conan G Kinsey
Pageof 19